Novartis India Ltd


BSE: 500672 | NSE: NOVARTIND | ISIN: INE234A01025 
Market Cap: [Rs.Cr.] 1,791 | Face Value: [Rs.] 5
Industry: Pharmaceuticals - Multinational

 Discuss this stock

Profit & Loss

(Rs. in Crores)
ParticularsMar-12Mar-11Mar-10Mar-09Mar-08Mar-07
INCOME :      
Sales Turnover 846.80752.63625.23602.52559.70548.16
Excise Duty2.511.421.312.016.577.31
Net Sales844.29751.21623.92600.51553.13540.85
Other Income 84.0167.3377.9666.0058.9450.85
Stock Adjustments 22.292.840.46-11.93-3.805.24
Total Income950.59821.38702.34654.58608.27596.94
EXPENDITURE :      
Raw Materials 333.77276.15251.13235.80236.90249.24
Power & Fuel Cost2.642.502.552.342.111.87
Employee Cost 131.65110.1083.5068.7558.1353.42
Other Manufacturing Expenses 65.1656.0038.6441.7232.4126.42
Selling and Administration Expenses 154.64129.96119.84105.33102.44107.65
Miscellaneous Expenses 34.8325.1024.3124.3418.5319.69
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure722.69599.81519.97478.28450.52458.29
Operating Profit227.90221.57182.37176.30157.75138.65
Interest 0.540.280.320.710.600.63
Gross Profit227.36221.29182.05175.59157.15138.02
Depreciation2.672.382.252.692.852.67
Profit Before Tax224.69218.91179.80172.90154.30135.35
Tax74.1772.5165.4265.1452.3943.07
Fringe Benefit tax0.000.000.005.104.315.56
Deferred Tax-1.50-0.27-1.61-1.050.37-1.83
Reported Net Profit152.02146.67115.99103.7197.2388.55
Extraordinary Items -0.07-0.05-0.05-0.232.771.48
Adjusted Net Profit152.09146.72116.04103.9494.4687.07
Adjst. below Net Profit 0.000.000.000.000.000.00
P & L Balance brought forward353.71258.85191.73135.7885.6642.41
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 52.3451.8148.8747.7647.1145.30
P & L Balance carried down453.39353.71258.85191.73135.7885.66
Dividend31.9631.9631.9631.9631.9631.96
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %200.00200.00200.00200.00200.00200.00
Earnings Per Share-Unit Curr45.9444.2734.6330.7528.7226.30
Earnings Per Share(Adj)-Unit Curr45.9444.2734.6330.7528.7226.30
Book Value-Unit Curr255.90219.96185.69161.06140.31121.58

Peer Comparison

Company Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Glaxosmit Pharma 19,660.14 29.70 9.78 18.86 34.3 45.2 0.00
Sanofi India 5,734.12 31.70 4.81 13.73 15.4 22.5 0.00
Pfizer 3,182.44 15.45 1.86 9.41 15.0 22.1 0.00
Abbott India 3,082.63 18.57 4.77 12.08 24.3 34.8 0.00
Fres.Kabi Onco. 2,022.59 22.55 3.41 22.38 3.5 5.4 0.42
Astrazeneca Phar 1,998.75 0.00 20.04 140.28 10.7 15.2 0.03
Wyeth 1,863.49 14.33 3.25 7.61 33.4 45.1 0.01
Novartis India 1,791.04 14.96 1.99 10.43 20.0 28.8 0.00
Merck 1,092.53 13.66 2.26 7.04 17.5 25.5 0.00
Fulford (India) 248.04 0.00 1.71 0.00 -3.4 -4.7 0.00
Organon (India) 159.14 0.00 0.98 0.00 15.3 22.8 0.00

Futures & Options Quote

 
Expiry Date
NA
Instrument: NA
Expiry Date: NA
Strike Price: NA
Open Price: NA
Average Price: NA
No. of Contracts Traded: NA
Open Interest: NA
Underlying: NA
Option Type: NA
Market Lot: NA
Previous Close: NA
Day’s High | Low: NA | NA
Turnover (Cr.): NA
Open Int. Change: NA | NA
View detailed F& O quotes >>

Key Information

Key Executives:

C Snook , Chairman 

R Shahani , Vice Chairman & M.D. 

J Hiremath , Director 

R Mehrotra , Director 


Company Head Office / Quarters:
Sandoz House Shivsagar Estate,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400018
Phone : 91-022-24988888/4802/4040/24958400
Fax : 91-022-24938666/24970361
E-mail : hemang.maniar@novartis.com
Web : http://www.novartis.co.in
Registrars:
Sharepro Services India P Ltd
Samhita Complex
Plot No 13 AB
Saki Naka Andheri(E)
Mumbai-400072

Fund Holding

 
Scheme Name No. of Shares
SBI Pharma Fund (D) 17,312

Calendar

May-2013
M T W T F S S
20 21 22 23 24 25 26
IPO
listIssue Opening : Just Dial
listIssue Open : Onesource Techm.
Economic Events
list Rightmove House Prices (YoY)
list Fed's Evans Speaks on Economy in Chicago
Results
list India Cements | Voltas | Apollo Hospitals | Future Retail